Juno Therapeutics

Jounce Therapeutics

This clinical-stage biopharmaceutical company develops immunotherapy treatments for cancer patients by using a platform that enables the immune system to attack tumours.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Cell Design Labs

This biotherapeutics company develops programmable cell therapies for cancer patients by engineering immune cells with synthetic genetic circuits to improve precision and safety.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Caribou Biosciences

This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.

Kite Pharma

This biopharmaceutical company develops and manufactures cancer immunotherapy products, specifically CAR T-cell therapies, for patients with blood cancers such as lymphoma and leukaemia.

Lyell Immunopharma

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies to treat patients with hematologic malignancies and solid tumours.